Budesonide;Formoterol Fumarate Dihydrate shortage — US supply status & alternatives

Budesonide;Formoterol Fumarate Dihydrate

—

In supply · Australia

Budesonide/Formoterol Teva Pharma B.V

In supply · 🇦🇺 Australia · short in🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Budesonide;Formoterol Fumarate Dihydrate

Therapeutic category	Auto-created by EMA — Withdrawn / Refused / Revoked Medicines scraper

Controlled substance	No

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Recalls official enforcement reports

🇺🇸

Budesonide Extended-Release Tablets

Golden State Medical Supply Inc. · Jan 2024

Class IIdetails ↗

🇺🇸

BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE

Cardinal Health Inc. · Mar 2021

Class IIdetails ↗

🌐

Budesonide/Formoterol Teva Pharma B.V.

Teva Pharma B.V. · Dec 2016

Class Unifieddetails ↗

🇺🇸

Budesonide Active Pharmaceutical Ingredient Packaged In Vary

Attix Pharmaceuticals · Nov 2014

Class IIdetails ↗

🇺🇸

Budesonide Capsules

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · May 2013

Class IIIdetails ↗

🇺🇸

Budesonide (P.F) Nasal Irrigation 0.5Mg/500Ml Solution 1000

Franck's Lab Inc., d.b.a. Franck's Compounding Lab · May 2012

Class IIdetails ↗

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.